Table 1 Review of tumor lysis syndrome in sarcomas
Author | Year | Patient age, years | Patient gender | Malignancy | Treatment(s) |
|---|---|---|---|---|---|
Qian et al. [23] | 2009 | 44 | Male | Retroperitoneal soft tissue sarcoma | Cisplatin Adriamycin Dacarbazine |
Gold et al. [24] | 1993 | 66 | Male | Gastric leiomyosarcoma | Cyclophosphamide Autolymphocyte transfusion |
Khan and Broadent [25] | 1993 | 9 | Female | Embryonal rhabdomyosarcoma | Carboplatin Epirubicin Vincristine |
Ahmed et al. [26] | 2019 | 71 | Female | Undifferentiated endometrial stromal sarcoma | Paclitaxel Carboplatin |
Hiraizumi et al. [27] | 2011 | 36 | Female | Epithelioid leiomyosarcoma (with focal rhabdomyosarcomatous differentiation) | Vincristine Actinomycin-D Cyclophosphamide |
Catania et al. [28] | 2017 | 65 | Female | Extraskeletal osteosarcoma | None (spontaneous) |